SinoMab BioScience Limited — Report Publication Announcement 2020

Aug 12, 2020

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [29 x 44] intentionally omitted <==

==> picture [36 x 44] intentionally omitted <==

==> picture [12 x 18] intentionally omitted <==

==> picture [15 x 18] intentionally omitted <==

==> picture [16 x 18] intentionally omitted <==

==> picture [17 x 18] intentionally omitted <==

==> picture [16 x 18] intentionally omitted <==

==> picture [12 x 18] intentionally omitted <==

SinoMab BioScience Limited 中 國 抗 體 製 藥 有 限 公 司

(Incorporated in Hong Kong with limited liability) (Stock code: 3681)

DATE OF BOARD MEETING

The board of directors (the “ Board ”) of SinoMab BioScience Limited (the “ Company ”, and its subsidiaries, the “ Group ”) hereby announces that a meeting of the Board will be held on Monday, 24 August 2020 for the purposes of considering and approving the interim results of the Group for the six months ended 30 June 2020 and the publication thereof, and transacting any other business.

By Order of the Board

SinoMab BioScience Limited Dr. Shui On LEUNG

Executive Director, Chairman and Chief Executive Officer

Hong Kong, 12 August 2020

As at the date of this announcement, the executive directors of the Company are Dr. Shui On LEUNG and Mr. Jing QIANG, the non-executive directors of the Company are Ms. Wenyi LIU, Dr. Haigang CHEN, Mr. Senlin LIU, Mr. Huiyuan MA and Mr. Xun DONG, and the independent non-executive directors of the Company are Mr. Dylan Carlo TINKER, Mr. Michael James Connolly HOGAN, Mr. Ping Cho Terence HON and Mr. George William Hunter CAUTHERLEY.